BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23478665)

  • 1. Maintenance of the hematopoietic stem cell pool in bone marrow niches by EVI1-regulated GPR56.
    Saito Y; Kaneda K; Suekane A; Ichihara E; Nakahata S; Yamakawa N; Nagai K; Mizuno N; Kogawa K; Miura I; Itoh H; Morishita K
    Leukemia; 2013 Aug; 27(8):1637-49. PubMed ID: 23478665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Maintenance of leukemic and normal hematopoietic stem cells in bone marrow niches by EVI1-regulated GPR56].
    Saito Y; Morishita K
    Rinsho Ketsueki; 2015 Apr; 56(4):375-83. PubMed ID: 25971267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietin1 contributes to the maintenance of cell quiescence in EVI1(high) leukemia cells.
    Ichihara E; Kaneda K; Saito Y; Yamakawa N; Morishita K
    Biochem Biophys Res Commun; 2011 Dec; 416(3-4):239-45. PubMed ID: 22033412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of GPR56 expression by pyrrole-imidazole polyamide represents a novel therapeutic drug for AML with high EVI1 expression.
    Saha HR; Kaneda-Nakashima K; Shimosaki S; Suekane A; Sarkar B; Saito Y; Ogoh H; Nakahata S; Inoue K; Watanabe T; Nagase H; Morishita K
    Sci Rep; 2018 Sep; 8(1):13741. PubMed ID: 30214063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression.
    Yuasa H; Oike Y; Iwama A; Nishikata I; Sugiyama D; Perkins A; Mucenski ML; Suda T; Morishita K
    EMBO J; 2005 Jun; 24(11):1976-87. PubMed ID: 15889140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia.
    Yamakawa N; Kaneda K; Saito Y; Ichihara E; Morishita K
    PLoS One; 2012; 7(1):e30706. PubMed ID: 22295105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis.
    Kataoka K; Kurokawa M
    Cancer Sci; 2012 Aug; 103(8):1371-7. PubMed ID: 22494115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells.
    Maicas M; Vázquez I; Alis R; Marcotegui N; Urquiza L; Cortés-Lavaud X; Cristóbal I; García-Sánchez MA; Odero MD
    Biochim Biophys Acta Gene Regul Mech; 2017 Jun; 1860(6):721-729. PubMed ID: 28391050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of the proapoptotic tumor suppressor gene Cell Adhesion Molecule 1 by chemotherapeutic agents is repressed in therapy resistant acute myeloid leukemia.
    Fisser MC; Rommer A; Steinleitner K; Heller G; Herbst F; Wiese M; Glimm H; Sill H; Wieser R
    Mol Carcinog; 2015 Dec; 54(12):1815-9. PubMed ID: 25491945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity.
    Kataoka K; Sato T; Yoshimi A; Goyama S; Tsuruta T; Kobayashi H; Shimabe M; Arai S; Nakagawa M; Imai Y; Kumano K; Kumagai K; Kubota N; Kadowaki T; Kurokawa M
    J Exp Med; 2011 Nov; 208(12):2403-16. PubMed ID: 22084405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
    Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
    Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of EVI1 in normal and leukemic cells.
    Buonamici S; Chakraborty S; Senyuk V; Nucifora G
    Blood Cells Mol Dis; 2003; 31(2):206-12. PubMed ID: 12972028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells.
    Shimabe M; Goyama S; Watanabe-Okochi N; Yoshimi A; Ichikawa M; Imai Y; Kurokawa M
    Oncogene; 2009 Dec; 28(49):4364-74. PubMed ID: 19767769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endoplasmic reticulum chaperone protein GRP94 is required for maintaining hematopoietic stem cell interactions with the adult bone marrow niche.
    Luo B; Lam BS; Lee SH; Wey S; Zhou H; Wang M; Chen SY; Adams GB; Lee AS
    PLoS One; 2011; 6(5):e20364. PubMed ID: 21647226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of EVI1 transcript levels in acute myeloid leukemia by RT-qPCR analysis: A study by the ALFA Group.
    Smol T; Nibourel O; Marceau-Renaut A; Celli-Lebras K; Berthon C; Quesnel B; Boissel N; Terré C; Thomas X; Castaigne S; Dombret H; Preudhomme C; Renneville A
    Leuk Res; 2015 Dec; 39(12):1443-7. PubMed ID: 26467814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The shortest isoform of C/EBPβ, liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model.
    Watanabe-Okochi N; Yoshimi A; Sato T; Ikeda T; Kumano K; Taoka K; Satoh Y; Shinohara A; Tsuruta T; Masuda A; Yokota H; Yatomi Y; Takahashi K; Kitaura J; Kitamura T; Kurokawa M
    Blood; 2013 May; 121(20):4142-55. PubMed ID: 23547050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-133 regulates Evi1 expression in AML cells as a potential therapeutic target.
    Yamamoto H; Lu J; Oba S; Kawamata T; Yoshimi A; Kurosaki N; Yokoyama K; Matsushita H; Kurokawa M; Tojo A; Ando K; Morishita K; Katagiri K; Kotani A
    Sci Rep; 2016 Jan; 6():19204. PubMed ID: 26754824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietin/MPL signaling confers growth and survival capacity to CD41-positive cells in a mouse model of Evi1 leukemia.
    Nishikawa S; Arai S; Masamoto Y; Kagoya Y; Toya T; Watanabe-Okochi N; Kurokawa M
    Blood; 2014 Dec; 124(24):3587-96. PubMed ID: 25298035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: Aberrant EVI1 expression in acute myeloid leukaemia.
    Hinai AA; Valk PJ
    Br J Haematol; 2016 Mar; 172(6):870-8. PubMed ID: 26729571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecotropic viral integration site 1, a novel oncogene in prostate cancer.
    Queisser A; Hagedorn S; Wang H; Schaefer T; Konantz M; Alavi S; Deng M; Vogel W; von Mässenhausen A; Kristiansen G; Duensing S; Kirfel J; Lengerke C; Perner S
    Oncogene; 2017 Mar; 36(11):1573-1584. PubMed ID: 27617580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.